Intravenous Immunoglobulin Resistant Kawasaki Disease

Publish Year: 1391
نوع سند: مقاله ژورنالی
زبان: English
View: 86

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JPRE-1-1_006

تاریخ نمایه سازی: 8 آذر 1402

Abstract:

ABSTRACT Kawasaki disease is a systemic vasculitis that mainly affects younger children. Although the definite cause still remains unknown but the clinical and epidemiologic findings discuss an infectious cause. The prevalence of incomplete Kawasaki disease reported ۱۵ to ۳۶.۲%, and it is more frequent in the extremes of the age spectrum. Non delayed treatment of disease should be initiated because of critical cardiac vascular complications. Up to ۱۵% - ۲۵% of patients with Kawasaki disease who remain febrile after administration of first dose of intravenous immunoglobin plus aspirin are classified as refractory disease. These intravenous immunoglobin resistant cases are at increasing risk for coronary artery complications. The strategy on prediction of potentially non responder and treatment of intravenous immunoglobin resistant patients is now controversial but some useful points were recommended.

Authors

Mohammad Reza Navaeifar

Nosocomial Infection Research Center

Mohammad Sadegh Rezai

Department of Pediatric Infectious Disease